Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/1995
08/23/1995EP0667789A1 Restoration of immunocompetency to t helper cells in hiv infected patients
08/23/1995EP0667786A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues
08/23/1995EP0574398B1 Utilization of immunoglobulines administered locally in the treatment of epithelial infections
08/23/1995EP0522010B1 Bcrf1 antagonists for treating epstein-barr virus infections
08/23/1995EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
08/22/1995US5444164 TGF-β induced gene
08/22/1995US5444158 Merosin, nucleic acids encoding, fragments and uses thereof
08/22/1995US5444156 Monoclonal antibodies to human plasma prekallikrein
08/22/1995US5444155 Molecules with antibody combining sites that induce asymmetry
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5443976 Making antivenoms of rattlesnakes by attaching two whole venoms having antibody binding capacity to insoluble aldehyde activated agarose substrate by covelentyl bonding
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443957 Cancer diagnosis
08/22/1995US5443956 Detection, quantitation and classification of RAS proteins in body fluids and tissues
08/22/1995US5443955 Receptor membranes and ionophore gating
08/22/1995US5443953 Genetic engineering; diagnosis, therapy
08/22/1995US5443952 Reacting a serum sample with sulfatide and determining the titer of antisulfatide igg and igm antibody that binds to sulfatide to diagnose neuropathy
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995CA1336763C Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement
08/22/1995CA1336760C Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells
08/17/1995WO1995021941A1 Methods of diagnosing ulcerative colitis and crohn's disease
08/17/1995WO1995021938A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
08/17/1995WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995WO1995021923A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor
08/17/1995WO1995021922A2 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
08/17/1995WO1995021921A1 Mammalian thymokine genes
08/17/1995WO1995021920A1 Hematopoietic protein and materials and methods for making it
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021914A1 Method for preparing a multicombinatorial library of antibody gene expression vectors
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021867A1 Granulocyte colony-stimulating factor receptor (g-csf-r) interactive molecules
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021864A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995WO1995021863A1 Prostaglandin i2 receptor
08/17/1995WO1995021861A1 Fk-506 cytosolic binding protein
08/17/1995WO1995021673A1 Preparation and application of artificial anti-idiotypic imprints
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183266A1 Hematopoietic protein and materials and methods for making it
08/17/1995CA2183254A1 Mammalian cell cycle protein
08/17/1995CA2183147A1 Methods of diagnosing ulcerative colitis and crohn's disease
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2183063A1 Prostaglandin i2 receptor
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182977A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995CA2182967A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995CA2182574A1 Mammalian thymokine genes
08/17/1995CA2182494A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995CA2182493A1 Granulocyte colony-stimulating factor receptor (g-csf-r) interactive molecules
08/17/1995CA2181803A1 Fk-506 cytosolic binding protein
08/17/1995CA2166313A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
08/17/1995CA2160591A1 Protein having tpo activity
08/16/1995EP0667395A1 Monoclonal antibody, process for producing the same, and use thereof
08/16/1995EP0667394A2 Recombinant antibody produced by transformed Bacillus bacteria
08/16/1995EP0667165A1 Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor
08/16/1995EP0666919A1 Vaccine containing a thiol protease
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666911A1 Multidrug resistance gene
08/16/1995EP0666905A1 Molecules with antibody combining sites that induce asymmetry
08/16/1995EP0666868A1 Vascular endothelial cell growth factor antagonists
08/16/1995EP0666867A1 Reagents and methods for treating rheumatoid arthritis
08/16/1995EP0666866A1 Method of isolating biomolecules by ion exchange
08/16/1995EP0666761A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies
08/16/1995EP0666760A1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
08/16/1995EP0605410B1 Immunodiagnostic assay for rheumatoid arthritis
08/16/1995EP0532525B1 New protein-polycation conjugates
08/16/1995EP0527809B1 Walk-through mutagenesis
08/16/1995EP0372071B1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
08/16/1995EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
08/16/1995EP0335901B1 Pentigetide for treating non-IgE-mediated inflammatory diseases
08/15/1995US5442050 Isolated DNA sequences
08/15/1995US5441934 Dna sequences
08/15/1995US5441932 Antiallergens, antiinflammatory agents
08/15/1995US5441880 Human cdc25 genes, encoded products and uses thereof
08/15/1995US5441871 Monoclonal antibody reactive to human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
08/15/1995US5441870 Methods for monitoring cellular processing of β-amyloid precursor protein
08/15/1995US5441868 Production of recombinant erythropoietin
08/15/1995US5441867 Pre-activated proteins for labelling oligonucleotide probes
08/15/1995US5441703 Having conicoidal interior contour which homogeneously widens flow of reactant gases
08/15/1995CA1336739C Diphosphonate-derivatized macromolecules
08/15/1995CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects
08/15/1995CA1336689C Determining cereal quality
08/11/1995CA2142171A1 Antibody encoding recombinant dna and its use
08/10/1995WO1995021258A1 Fusion proteins that include antibody and nonantibody portions
08/10/1995WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995WO1995021248A1 Method for using tobacco mosaic virus to overproduce peptides and proteins
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995021244A1 Monoclonal antibody 88bv59, subclones and method of making
08/10/1995WO1995021243A2 Operating procedure for the in vivo production of immunological products and cells and the in vivo testing of immune-modulating substances
08/10/1995WO1995021196A1 Immunoassay for inositols
08/10/1995WO1995021195A1 Non-viral vector
08/10/1995WO1995021189A1 Hepatitis b vaccine
08/10/1995WO1995020978A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
08/10/1995WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995WO1995020959A1 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
1 ... 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 ... 1494